SE Fineberg, MJ Rathbun, S Hufferd, NS … - Diabetes, 1988 - Am Diabetes Assoc We investigated the immunogenicity of human proinsulin (HPI) when used as the
sole or principal insulin agonist in insulin-naive patients with
insulin-dependent (type I) and non-insulin-dependent (type II) diabetes ... Cited by 10 - Related articles - All 5 versions
[CITATION] Immunologic effects of insulin lispro [Lys (B23), Pro (B29) human insulin] in IDDM and NIDDM …
L Jovanovic-Peterson, JL Kitzmiller, CM … - American journal of obstetrics and gynecology, 1992 - grande.nal.usda.gov Record Detail. Return to previous page, Save: Title: Randomized trial of
human versus animal species insulin in diabetic pregnant ... Cited by 18 - Related articles - Cached - BL Direct - All 3 versions
L Jovanovic, S Martin - Type 2 Diabetes Mellitus: An Evidence-Based …, 2008 - Springer Summary In 1997, the American Diabetes Association (ADA) announced new
diagnostic criteria (1) for diabetes and set the definition of gestational
diabetes (GDM). Before 1991, GDM was defined as “a transient abnormality ... Related articles - All 2 versions
HL Eichner, AA Lauritano, LL Woertz, JL … - Diabetes research (Edinburgh, Scotland), 1988 - ncbi.nlm.nih.gov To evaluate the immunogenicity of human insulin preparations, the treatment of
10 insulin-dependent diabetic patients was changed from purified porcine
insulins to lente and regular semisynthetic human insulin (SSHI, N = 5) or ... Cited by 1 - Related articles - All 2 versions
R Gomis, A Recasens, M Peig, R Casamitjana, R … - Autoimmunity, 1988 - informahealthcare.com Autoimmunity, 1988, Vol. 1, pp. 299-305 Reprints available directly from the
publisher Photocopying permitted by license only ... 0 1988 Harwood Academic
Publishers GmbH Printed in Great Britain ... PRESENCE OF INSULIN ... Cited by 2 - Related articles - All 4 versions
R Klauser, R Prager, B Watschinger, G … - European Journal of Clinical Investigation, 1989 - interscience.wiley.com Abstract. Due to a longer plasma half-life and half-time of action on glucose
metabolism biosynthetic human proinsulin was thought to be an alternative to
long-acting insulin preparations. To test this hypothesis we studied 23 ... Cited by 2 - Related articles - All 3 versions
